CALPRO AS
Page date: No publication date displayed; copyright footer 2026.
Calpro says it focuses on the biomarker calprotectin and prognostic e-health tools for home monitoring of patients with autoimmune disease, particularly inflammatory bowel disease (IBD). Listed address: Arnstein Arnebergs vei 30, 1366 Lysaker, Norway; website: calpro.no. Industry: Health and life science.
The profile includes two company case-study links: a paper on patients measuring faecal calprotectin at home with smartphones, and a study of Ampersand Health’s My IBD Care app with CalproSmart® integration. The Products tab links to CalproSmart® remote monitoring for IBD patients using the calprotectin biomarker. The Events tab lists a past Team Norway event, “New Ways of Working: Transforming how Hospitals work in Norway and the UK,” held in London on 6 October 2025, 18:00–21:00 GMT. Public contact listing: Ingvild Haukø, VP Market Development, mail@calpro.no; no phone number is displayed.
Related links: CalproSmart remote monitoring; Oxford Academic case study; My IBD Care case study; hospital-work event.